Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1303 | 2729 | 32.6 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
332 | 3 | ERYTHROPOIETIN//ANEMIA//FERRITIN | 37752 |
388 | 2 | ERYTHROPOIETIN//ANEMIA//IRON DEFICIENCY | 16969 |
1303 | 1 | ERYTHROPOIETIN//ANEMIA//ERYTHROPOIESIS STIMULATING AGENTS | 2729 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ERYTHROPOIETIN | authKW | 921114 | 24% | 12% | 662 |
2 | ANEMIA | authKW | 662135 | 24% | 9% | 644 |
3 | ERYTHROPOIESIS STIMULATING AGENTS | authKW | 660746 | 5% | 41% | 144 |
4 | DARBEPOETIN ALFA | authKW | 555683 | 4% | 45% | 111 |
5 | EPOETIN | authKW | 487218 | 4% | 45% | 97 |
6 | RENAL ANEMIA | authKW | 473324 | 3% | 48% | 88 |
7 | RECOMBINANT HUMAN ERYTHROPOIETIN | authKW | 370646 | 4% | 29% | 115 |
8 | ANAEMIA | authKW | 265725 | 9% | 10% | 237 |
9 | CERA | authKW | 239712 | 1% | 71% | 30 |
10 | CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR | authKW | 229161 | 1% | 79% | 26 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 122641 | 61% | 1% | 1675 |
2 | Transplantation | 13039 | 15% | 0% | 399 |
3 | Medicine, General & Internal | 1264 | 11% | 0% | 311 |
4 | Hematology | 749 | 6% | 0% | 159 |
5 | Engineering, Biomedical | 504 | 4% | 0% | 108 |
6 | Pharmacology & Pharmacy | 286 | 9% | 0% | 235 |
7 | Medicine, Research & Experimental | 256 | 5% | 0% | 131 |
8 | Peripheral Vascular Diseases | 221 | 3% | 0% | 93 |
9 | Pediatrics | 90 | 3% | 0% | 83 |
10 | Endocrinology & Metabolism | 47 | 3% | 0% | 80 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEPHROL DIALYSIS RENAL TRANSPLANT | 62153 | 1% | 33% | 17 |
2 | CHRON DIS GRP | 58461 | 1% | 15% | 34 |
3 | NEPHROL | 51974 | 20% | 1% | 544 |
4 | AFFILIATED HOSP HENAN PROV | 33562 | 0% | 100% | 3 |
5 | RENAL MED | 30703 | 4% | 3% | 99 |
6 | NEPHROL ANALYT SERV | 30193 | 0% | 30% | 9 |
7 | ANAEMIA COORDINATOR PROGRAMME | 22375 | 0% | 100% | 2 |
8 | COURSE SAFETY MANAGEMENT HLTH CARE SCI | 22375 | 0% | 100% | 2 |
9 | DIAVERUM GRP | 22375 | 0% | 100% | 2 |
10 | MED LEAD RENAL SERV | 22375 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEPHROLOGY DIALYSIS TRANSPLANTATION | 71452 | 10% | 2% | 281 |
2 | AMERICAN JOURNAL OF KIDNEY DISEASES | 47634 | 7% | 2% | 190 |
3 | CLINICAL NEPHROLOGY | 19093 | 3% | 2% | 92 |
4 | BLOOD PURIFICATION | 16415 | 2% | 3% | 49 |
5 | NEFROLOGIA | 15770 | 2% | 2% | 60 |
6 | NEPHROLOGY | 13372 | 2% | 2% | 51 |
7 | SEMINARS IN NEPHROLOGY | 13366 | 2% | 3% | 48 |
8 | DIALYSIS & TRANSPLANTATION | 13281 | 1% | 3% | 39 |
9 | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 12547 | 2% | 2% | 56 |
10 | AMERICAN JOURNAL OF NEPHROLOGY | 12371 | 2% | 2% | 60 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERYTHROPOIETIN | 921114 | 24% | 12% | 662 | Search ERYTHROPOIETIN | Search ERYTHROPOIETIN |
2 | ANEMIA | 662135 | 24% | 9% | 644 | Search ANEMIA | Search ANEMIA |
3 | ERYTHROPOIESIS STIMULATING AGENTS | 660746 | 5% | 41% | 144 | Search ERYTHROPOIESIS+STIMULATING+AGENTS | Search ERYTHROPOIESIS+STIMULATING+AGENTS |
4 | DARBEPOETIN ALFA | 555683 | 4% | 45% | 111 | Search DARBEPOETIN+ALFA | Search DARBEPOETIN+ALFA |
5 | EPOETIN | 487218 | 4% | 45% | 97 | Search EPOETIN | Search EPOETIN |
6 | RENAL ANEMIA | 473324 | 3% | 48% | 88 | Search RENAL+ANEMIA | Search RENAL+ANEMIA |
7 | RECOMBINANT HUMAN ERYTHROPOIETIN | 370646 | 4% | 29% | 115 | Search RECOMBINANT+HUMAN+ERYTHROPOIETIN | Search RECOMBINANT+HUMAN+ERYTHROPOIETIN |
8 | ANAEMIA | 265725 | 9% | 10% | 237 | Search ANAEMIA | Search ANAEMIA |
9 | CERA | 239712 | 1% | 71% | 30 | Search CERA | Search CERA |
10 | CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR | 229161 | 1% | 79% | 26 | Search CONTINUOUS+ERYTHROPOIETIN+RECEPTOR+ACTIVATOR | Search CONTINUOUS+ERYTHROPOIETIN+RECEPTOR+ACTIVATOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PALMER, SC , SAGLIMBENE, V , MAVRIDIS, D , SALANTI, G , CRAIG, JC , TONELLI, M , WIEBE, N , STRIPPOLI, GFM , (2014) ERYTHROPOIESIS-STIMULATING AGENTS FOR ANAEMIA IN ADULTS WITH CHRONIC KIDNEY DISEASE: A NETWORK META-ANALYSIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 111 | 69% | 3 |
2 | HAHN, D , CODY, JD , HODSON, EM , (2014) FREQUENCY OF ADMINISTRATION OF ERYTHROPOIESIS-STIMULATING AGENTS FOR THE ANAEMIA OF END-STAGE KIDNEY DISEASE IN DIALYSIS PATIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 5. P. - | 75 | 94% | 2 |
3 | LOCATELLI, F , ALJAMA, PA , BARANY, P , CANAUD, B , CARRERA, F , ECKARDT, KU , HORL, WH , MACDOUGALL, IC , MACLEOD, A , WIECEK, A , ET AL (2004) REVISED EUROPEAN BEST PRACTICE GUIDELINES FOR THE MANAGEMENT OF ANAEMIA IN PATIENTS WITH CHRONIC RENAL FAILURE.NEPHROLOGY DIALYSIS TRANSPLANTATION. VOL. 19. ISSUE . P. 1-47 | 128 | 46% | 315 |
4 | SCHMID, H , (2016) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA FOR THE TREATMENT OF ANEMIA ASSOCIATED WITH CHRONIC RENAL FAILURE.EXPERT REVIEW OF HEMATOLOGY. VOL. 9. ISSUE 1. P. 5 -20 | 71 | 84% | 0 |
5 | KRAPF, R , HULTER, HN , (2009) ARTERIAL HYPERTENSION INDUCED BY ERYTHROPOIETIN AND ERYTHROPOIESIS-STIMULATING AGENTS (ESA).CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 4. ISSUE 2. P. 470-480 | 64 | 90% | 69 |
6 | PALMER, SC , SAGLIMBENE, V , CRAIG, JC , NAVANEETHAN, SD , STRIPPOLI, GFM , (2014) DARBEPOETIN FOR THE ANAEMIA OF CHRONIC KIDNEY DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 63 | 93% | 3 |
7 | HORL, WH , (2013) ANAEMIA MANAGEMENT AND MORTALITY RISK IN CHRONIC KIDNEY DISEASE.NATURE REVIEWS NEPHROLOGY. VOL. 9. ISSUE 5. P. 291-301 | 61 | 75% | 33 |
8 | KOULOURIDIS, I , ALFAYEZ, M , TRIKALINOS, TA , BALK, EM , JABER, BL , (2013) DOSE OF ERYTHROPOIESIS-STIMULATING AGENTS AND ADVERSE OUTCOMES IN CKD: A METAREGRESSION ANALYSIS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 61. ISSUE 1. P. 44-56 | 48 | 91% | 37 |
9 | LEVIN, A , ROCCO, M , (2007) KDCQI CLINICAL PRACTICE GUIDELINE AND CLINICAL PRACTICE RECOMMENDATIONS FOR ANEMIA IN CHRONIC KIDNEY DISEASE: 2007 UPDATE OF HEMOGLOBIN TARGET.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 50. ISSUE 3. P. 471-530 | 43 | 90% | 255 |
10 | ESCHBACH, J , DEOREO, P , ADAMSON, J , BERNS, J , BIDDLE, G , COMSTOCK, T , JABS, K , LAZARUS, JM , NISSENSON, A , STIVELMAN, J , ET AL (1997) NKF-DOQI CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT OF ANEMIA OF CHRONIC RENAL FAILURE.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 30. ISSUE 4. P. S192 -S240 | 125 | 58% | 21 |
Classes with closest relation at Level 1 |